OTCPK:ALLQ

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

ALL-Q-TELL Corp., through its subsidiaries, develops integrated solutions in the areas of security, intelligence, and law enforcement for addressing threats to the United States and other its allies nations’ national security. More Details


Snowflake Analysis

Excellent balance sheet with weak fundamentals.

Share Price & News

How has ALL-Q-TELL's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ALLQ has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

ALLQ

-2.3%

US Healthcare

-0.8%

US Market


1 Year Return

n/a

ALLQ

21.0%

US Healthcare

13.8%

US Market

Return vs Industry: Insufficient data to determine how ALLQ performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how ALLQ performed against the US Market.


Shareholder returns

ALLQIndustryMarket
7 Day0%-2.3%-0.8%
30 Day0%-4.9%-5.7%
90 Dayn/a0.4%8.6%
1 Yearn/a22.6%21.0%16.4%13.8%
3 Yearn/a23.9%18.5%36.9%27.8%
5 Yearn/a50.0%39.4%85.0%64.2%

Price Volatility Vs. Market

How volatile is ALL-Q-TELL's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is ALL-Q-TELL undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether ALL-Q-TELL is trading at an attractive price based on the cash flow it is expected to produce in the future. But as ALL-Q-TELL has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Examine ALL-Q-TELL's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through ALL-Q-TELL regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is ALL-Q-TELL forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ALL-Q-TELL has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has ALL-Q-TELL performed over the past 5 years?

8.7%

Historical Healthcare annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, ALL-Q-TELL has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

  • Examine ALL-Q-TELL's financial health to determine how well-positioned it is against times of financial stress by looking at its level of debt over time and how much cash it has left.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access ALL-Q-TELL's filings and announcements here.
  • Explore strong past performing companies in the Healthcare industry.

Financial Health

How is ALL-Q-TELL's financial position?


In this section we usually analyse ALL-Q-TELL's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. ALL-Q-TELL has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of ALLQ’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when ALL-Q-TELL's financial data was last updated here.
  • Explore more healthy companies in the Healthcare industry.

Dividend

What is ALL-Q-TELL current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ALLQ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ALLQ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ALLQ's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ALLQ's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ALLQ's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

9.8yrs

Average management tenure


CEO

Roy Mers (73 yo)

no data

Tenure

Roy W. Mers serves as Chief Executive Officer of ALL-Q-TELL Corp. (formerly known as Sleep Holdings, Inc.). Mr. Mers served as Chief Executive Officer of Regent Technologies Inc. since March, 1997. From Ma ...


Leadership Team

NamePositionTenureCompensationOwnership
Don Hodge
Chairman and Presidentno datano datano data
Roy Mers
Chief Executive Officer and Directorno datano datano data
David Dafinoiu
Chief Operating Officer10.67yrsno datano data
Michael Starkweather
Executive Vice President and General Counsel8.58yrsno datano data
Steve Spink
Vice President of Marketingno datano datano data
Thomas Bowers
Secretary14.17yrsno datano data

9.8yrs

Average Tenure

Experienced Management: ALLQ's management team is seasoned and experienced (9.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Don Hodge
Chairman and Presidentno datano datano data
Roy Mers
Chief Executive Officer and Directorno datano datano data
Thomas Bowers
Secretary14.17yrsno datano data
Charles Yost
Member of Advisory Board13.75yrsno datano data
J. Dunn
Member of Advisory Board13.75yrsno datano data
James O'Brien
Member of Clinical Advisory Boardno datano datano data
James Gaines
Director14.17yrsno datano data
Timothy Snodgrass
Member of Strategic Advisory Board13.75yrsno datano data
Michael Breus
Chairman of Clinical Advisory Board13.67yrsno datano data
George Korkos
Chairman of Business Advisory Board13yrsno datano data
Russell Rosenberg
Member of Clinical Advisory Board12.83yrsno datano data
Mauricio Reinoso
Member of Clinical Advisory Boardno datano datano data

13.8yrs

Average Tenure

72yo

Average Age

Experienced Board: ALLQ's board of directors are seasoned and experienced ( 13.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

ALL-Q-TELL Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: ALL-Q-TELL Corp.
  • Ticker: ALLQ
  • Exchange: OTCPK
  • Founded:
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$72.194k
  • Shares outstanding: 360.97m

Location

  • ALL-Q-TELL Corp.
  • 2974 LBJ Freeway
  • Suite 401
  • Dallas
  • Texas
  • 75234
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ALLQOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJul 2003

Biography

ALL-Q-TELL Corp., through its subsidiaries, develops integrated solutions in the areas of security, intelligence, and law enforcement for addressing threats to the United States and other its allies nation ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/07 05:46
End of Day Share Price2020/06/10 00:00
Earnings2009/06/30
Annual Earnings2009/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.